Earnings season is the heartbeat of the market - and every day brings fresh signals about where money is flowing.
With each report, we learn not just how companies are performing, but how investors are reacting.
In the Daily Beat, we spotlight the most important S&P 500 earnings moves from the prior session - the winners, the losers, and the reactions that reveal what really matters to the market right now.
Whether itβs a bellwether with broad economic implications or a niche name making waves, we cut through the noise to focus on the setups that matter most.
Here are the top beats from the S&P 500 π
*Click the image to enlarge it
At the top of Tuesday's list was MSCI Inc. $MSCI, a $45B provider of global indexes and financial data. The company reported mixed results, but the market rewarded shareholders with a +5.21 reaction score.
In the report, they posted revenues of $790M, below the expected $800M, and earnings per share were $4.47, above the expected $4.38.
Coming in second place was the biopharma behemoth, Regeneron $REGN. They delivered a double beat and had a +4.43 reaction score.
Revenues came in at $3.75B, compared to the expected $3.59B, and earnings per share of $11.83, above the expected $9.66.
Here are the bottom beats from the S&P 500 π
At the bottom of Tuesday's list was the $11B REIT that develops and operates life science and technology campuses in major innovation hubs across the U.S., Alexandria Real Estate $ARE. The company missed expectations across the board and suffered a -8.52 reaction score.
They reported revenues of $740M, missing the expected $750M, and earnings per share of -$1.38, well below the expected $0.50.
The $13B enterprise hardware and software stock, Zebra Technologies $ZBRA, posted a double beat, but had the second-worst reaction score of -5.35.
Revenues came in at $1.32B, above the expected $1.31B, and earnings per share came in 13 cents above expectations.
Now let's dive into the fundamentals and technicals π
REGN had its best earnings reaction since 2012 π₯
Regeneron had a +11.8% post-earnings reaction, and here's what happened:
Revenues and net income increased year-over-year by 1% and 9%, respectively.
Their leading drug, Dupixent, grew sales by a staggering 27% year-over-year.
In addition to the excellent report, the management team raised its forward guidance and expects to launch a handful of new products next year.
Biotech has been on a heater lately, and this stock has been a major laggard. From the August 2024 to June 2025 low, the price cratered 60%.
All of this changed after yesterday's earnings reaction...
Not only did the stock have its best earnings reaction in over a decade, but the price decisively resolved a textbook bearish-to-bullish reversal pattern. Now the bulls are back in control of the primary trend.
So long as REGN holds above 618, the path of least resistance will likely remain higher for the foreseeable future.
ARE had its worst earnings reaction ever π»
Alexandria Real Estate had a -19.2% post-earnings reaction, and here's what happened:
Coming as a major surprise to the market, the company reported a net loss attributable to common stockholders. Additionally, revenues declined by 5% year-over-year.
Rental rate growth for renewals came in at the high end of the prior guidance range.
Driving the selling pressure was the management team's forward guidance, which lowered its 2026 occupancy expectations.
This is one of the hottest messes in the entire S&P 500, and based on this quarter's results, things are getting worse.
The fundamentals have been deteriorating for years as shareholders have been punished for five of the last six earnings reports.
The stock has fallen by more than 70% from its all-time high in late 2021, and it's now at a significant level of former support from over a decade ago. If the buyers don't step in here, a fresh leg lower will likely follow.
So long as ARE holds above 61, the stock will likely bounce from here. If and when the price closes below that level, the path of least resistance will shift lower toward the GFC lows.
Happy Hump Day
-The Beat Team
P.S. The Federal Reserve is meeting today, and Jason Perz, Sam Gatlin, and Spencer Israel are going LIVE to talk about it. Clear your calendar for 2:00 pm ET and join us on Stock Market TV.
